Navigation Links
EMBO Gold Medal 2011 awarded to Simon Boulton

Heidelberg, Germany, 20 April 2011 - The European Molecular Biology Organization (EMBO) today announced Simon Boulton of Cancer Research UK's London Research Institute, Clare Hall Laboratories as the winner of the 2011 EMBO Gold Medal. Awarded annually, the EMBO Gold Medal recognizes the outstanding contributions of young researchers in the molecular life sciences.

Boulton receives the award in recognition of his groundbreaking research on DNA repair mechanisms. The election committee was particularly impressed by his pioneering role in establishing the nematode worm, C. elegans, as a model system to study genome instability.

"I am delighted and honoured to receive such a prestigious award," said Boulton upon hearing the news.

Throughout his career, 38-year-old Boulton and his research team have exploited the experimental strengths of several complementary systems, including C. elegans and mouse genetics, proteomics in mammalian cells and in vitro biochemistry. Some of their most important discoveries have come from contrasting the results obtained in different systems and cellular contexts. Boulton's PhD supervisor Stephen P. Jackson described him as an "absolutely outstanding scientist" and praised his unique combination of approaches that allowed him to make seminal contributions to the field encompassing DNA repair, genome instability and cancer.

Simon Boulton's research highlights include:

  • Discovering the gene RTEL1 as an anti-recombinase that impacts on genome stability and cancer and counteracts toxic recombination, which is also required in meiosis to execute non-crossover repair.

  • Discovering the PBZ motif and establishing that ALC1 (Amplified in Liver Cancer 1) is a poly(ADP-ribose)-activated chromatin-remodelling enzyme required for DNA repair. Poly (ADP-ribosyl)ation (PAR) is a post-translational modification of proteins that play an important role in mediating protein interactions and the recruitment of specific protein targets. These results provided new insights into the mechanisms by which PAR regulates DNA repair.

  • Discovering that the Fanconi Anemia proteins FANCM and FAAP24 are required for checkpoint-kinase signalling (ATR) in response to DNA damage and establishing that DNA repair defects of Fanconi Anemia cells can be suppressed by blocking error prone repair by non-homologous end joining.

Potential opportunities for cancer treatment

These discoveries gave rise to novel therapeutic approaches. Boulton's laboratory demonstrated that cells that over-express the ALC1 enzyme are highly susceptible to eradication by the chemotherapeutic Bleomycin. Since ALC1 is amplified in over 50 percent of human liver cancers, these findings may have important implications for liver cancer treatment.

The prizewinner also showed that DNA repair defects of Fanconi Anemia cells can be suppressed by blocking non-homologous end joining (NHEJ). This observation raises the possibility that NHEJ inhibitors could be used to suppress cancer predisposition in Fanconi Anemia patients.

Career stages

The UK-born scientist started his quest to investigate mechanisms of DNA repair while studying for his PhD at the University of Cambridge from 1994-1998. He describes his first exposure to the highly competitive world-class research environment in Cambridge as "extremely influential". Boulton also recognizes that establishing his own research group at the world-renowned Cancer Research UK's London Research Institute (LRI), Clare Hall Laboratories in 2002 was a key step in his scientific career.

Boulton, while still a young researcher, has been recognized with awards from both UK and international organizations, including the Colworth Medal from the Biochemistry Society and the Eppendorf/Nature Award. He became an EMBO Young Investigator in 2007 and an EMBO Member in 2009. This year he received a Wolfson Research Merit Award from the Royal Society and an Advanced Investigator Award from the ERC.

Simon Boulton will receive the EMBO Gold Medal and an award of 10,000 euros on 12 September 2011 at The EMBO Meeting in Vienna where he will give a lecture about his research.


Contact: Suzanne Beveridge
European Molecular Biology Organization

Related medicine news :

1. Multiple Medalist Kristina Groves Matches Hain Celestials $5,000 Donation to Right to Play
2. PA Hypnosis Center Uses 'Smart Training' Sports Psychology for Gold Medal Success
3. PNNLs Posakony honored with AAES 2009 John Fritz Medal
4. Olympic Gold Medalist Endorses Health Enterprises AfterSwim & Swim-Fit
5. Larson, McBride named 2010 ASTRO Gold Medalists
6. UCSFs Prusiner receives Presidents National Medal of Science
7. National Medal of Science awarded to Stephen Benkovic of Penn State University
8. Earl Smith receives Prentice Medal from American Academy of Optometry
9. Top Swedish scientist professor Bertil Andersson awarded prestigious Wilhelm Exner Medal in Vienna
10. San Diego Unified School District Awarded Silent Hero Grant From got breakfast?(R) Foundation
11. $250,000 grant awarded for groundbreaking ligament and tendon repair research
Post Your Comments:
(Date:11/30/2015)... ... 30, 2015 , ... The Progressive Dental Institute ... 29 and 30, 2016. The course welcomes dental professionals and members of their ... how to better succeed in the modern dental marketplace. The course combines presentations ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... key disease-causing component of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus ... State University. , Their study showed that small molecule analogs that target the ...
(Date:11/30/2015)... NJ (PRWEB) , ... November 30, 2015 , ... Dr. ... With three office locations, patients can visit Dr. Margulies to experience the best available ... to hold the title of "NJ Top Dentist"! , Orthodontics is the branch of ...
(Date:11/30/2015)... ... November 30, 2015 , ... ”Dying Words: The AIDS Reporting ... on December 1, 2015, to coincide with World AIDS Day. The multi-media project will ... covered the AIDS epidemic as he was dying of the disease. , A collaborative ...
(Date:11/30/2015)... ... November 30, 2015 , ... According to RF Safe, the ... scientist at Consumer Reports as supporting a “A Call for Clarity” on cell ... The original Nov 2015 CR story titled, “Does Cell-Phone Radiation Cause Cancer?” ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... -- Kevin Smith has been appointed Chief Commercial Officer ... wireless monitoring of vital signs.  As CCO based ... Smith will be responsible for the development and ... also directly oversee partnering with US hospitals and ... the first early warning detection device to be ...
(Date:11/30/2015)... Nov. 30, 2015  The fee-for-service reimbursement ... U.S. medical imaging is on its way ... care payer-provider contracts are set to phase ... wake, alter provider-vendor relationships. The shift to ... forward new purchasing frameworks in the medical ...
(Date:11/30/2015)... SAN DIEGO , Nov. 30, 2015 ... ARNA ) today announced that the U.S. Food ... New Drug Application (NDA) for an extended release formulation ... offer patients a chronic weight management treatment in a ... currently approved as an adjunct to a reduced-calorie diet ...
Breaking Medicine Technology: